
There are few data regarding the use of zzso in children undergoing zzso therapy for zzso even though zzso is a known risk in pediatric patients with zzso zzso zzso such as zzso has become widely used in adult patients with zzso The purpose of this study was to review the zzso of zzso zzso zzso zzso in children with cancer at our institution who had zzso while undergoing zzso zzso In particular we were interested in the efficacy of zzso in these patients, and in whether these children were able to continue their chemotherapy without adjustment or interruption secondary to bleeding zzso We conducted a retrospective review from 1999 through April 1, zzso Seven patients zzso years of zzso were zzso Diagnosis included zzso acute zzso leukemia zzso zzso zzso Hodgkin's disease, zzso large cell lymphoma, and zzso zzso zzso Six patients had a deep vein zzso zzso or zzso of the zzso zzso One of these six patients also had a pulmonary zzso One patient presented with manifestations of a unilateral cerebral vascular accident without evidence of zzso Most patients were screened for known zzso zzso Treatment was zzso zzso zzso twice daily to maintain a zzso zzso level of zzso zzso till zzso zzso The dose was then decreased to daily for a total of 3-6 months of zzso All patients had resolution of their zzso within 1-2 months of initiation of zzso and none required delays or dose reduction of their chemotherapy regimens while on zzso though some were supported by blood and zzso zzso zzso was safely administered to this series of seven patients for zzso complications in children undergoing cancer zzso 

